Gender: Female
WCM Physician (What is this?)
NewYork-Presbyterian/Lower Manhattan Cancer Center
21 West Broadway
New York, NY 10007
Weill Cornell Medicine Radiation Oncology
525 East 68th Street , Stich Radiation Center
New York, NY 10065
(212) 746-8749
(212) 746-3600
Radiation Oncology at David H. Koch Center
1283 York Avenue , 4th Floor
New York, NY 10065
(212) 746-3607

Insurance Plans Accepted

The following represents most of the managed care plans accepted by this physician. If your insurance carrier does not appear here please contact the physician’s office as they may have individual contracts not included on this site.

* indicates this physician is no longer accepting new patients with this insurance plan.

  • AETNA - Medicare
  • Aetna - Weill Cornell - POS
  • Affinity Access
  • Affinity Health Plan
  • Amida Care
  • Blue Priority Network
  • Emblem Select Care
  • Empire Blue Cross/Blue Shield - Pathway X
  • Empire Blue Cross/Blue Shield - Pathway X Enhanced
  • Empire Blue Cross/Blue Shield - PPO
  • Empire Blue Cross/Blue Shield - Mediblue (Senior)
  • Empire Blue Cross/Blue Shield - HMO
  • Empire Blue Cross/Blue Shield - EPO
  • Empire Empire Blue Cross/Blue Shield HealthPlus
  • Empire Empire Blue Cross/Blue Shield HealthPlus - CHP
  • Fidelis Care
  • GHI - CBP
  • Health First
  • Health Insurance Plan of NY (HIP) - Medicare
  • Health Insurance Plan of NY (HIP) - Medicaid
  • Health Insurance Plan of NY (HIP)
  • Medicaid
  • Medicare
  • Oxford Health Plans - Metro/Core/Charter
  • Oxford Health Plans - Medicare Advantage
  • Oxford Health Plans - Liberty
  • Oxford Health Plans - Freedom
  • Rockefeller University - CoreSource
  • UHC Compass
  • United Empire
  • United Health Care - Community Plan
  • United Health Care - Medicare
  • United Health Care
  • VNSNY CHOICE - Medicare
  • WellCare Health Plans
  • WellCare Health Plans
  • WellCare Health Plans


Board Certifications

  • Radiation Oncology

Clinical & Academic Positions

Assistant Attending Radiation Oncologist
NewYork-Presbyterian Hospital

Assistant Professor of Clinical Radiation Oncology
Weill Cornell Medical College, Cornell University

Abby Joseph Cohen Clinical Scholar in Women's Health
Weill Cornell Medical College, Cornell University

Education & Training

  • M.D., Ph.D., New York University School of Medicine, 2007
  • B.A., New York University, 1998


Dr. Kang is a Board Certified Radiation Oncologist who received her MD and PhD at New York University where she completed her graduate thesis in the lab of renown microbiome expert, Dr. Martin J. Blaser.  She completed residency at the Harvard Medical School Combined Program in Boston, MA and was awarded the 2011 AACR Women in Cancer Research award for the development of a molecular signature to predict ovarian cancer outcomes.

She is the author of over 50 manuscripts, abstracts and book chapters, and is the Director of Clinical Research at New York Presbyterian/Queens. Presently, she is the online update editor of gynecologic malignancies for Perez and Brady’s Principles and Practice of Radiation Oncology, and also serves as an adjunct faculty at New York University in the Department of Medicine.

Dr. Kang’s research focus is on the human microbiome and how it can be harnessed to improve cancer treatment efficacy. She is working with Dr. Silvia Formenti, Chair of Radiation Oncology at NYP/Weill Cornell Medicine, whose groundbreaking work has shown immunotherapy combined with radiation can control cancer cell growth. While at NYU, they developed a protocol to study the cutaneous microbiome in breast cancer patients, and are now exploring the microbiome impact on immune checkpoint blockade (CTLA-4, PD-L1 inhibitors) and conversion of irradiated tumors into an in-situ vaccine.  

Dr. Kang is familiar with all modalities of radiation oncology, including 3D conformal RT, intensity modulated RT (IMRT), high dose rate (HDR) brachytherapy, protons and stereotactic body radiation therapy/radiosurgery (SBRT). She has published on long-term quality of life and disease outcomes for 5-fraction SBRT for prostate cancer, which has been presented at multiple national and international conferences. Her clinical expertise is on use of stereotactic radiation for treatment of cancer, with special focus on genitourinary malignancies.